Overexpression of Nrp/b (nuclear restrict protein in brain) suppresses the malignant phenotype in the C6/ST1 glioma cell line

Journal of Steroid Biochemistry and Molecular Biology

Volumn 117, Issue 4-5, 2009, Pages 107-116

  Degaki, Theri Leica ^a   Demasi, Marcos Angelo Almeida ^a   Sogayar, Mari Cleide ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

C6 ST1 cell line; Nrp b (nuclear restrict protein in brain); Nrp b overexpression; Suppression of the tumoral phenotype

Indexed keywords

CELL PROTEIN; COMPLEMENTARY DNA; MESSENGER RNA; NUCLEAR RESTRICT PROTEIN IN BRAIN; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GLIOMA; GLIOMA CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MONOLAYER CULTURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CLONING, MOLECULAR; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MICROFILAMENT PROTEINS; MOLECULAR SEQUENCE DATA; NEUROPEPTIDES; NUCLEAR PROTEINS; RATS; SEQUENCE HOMOLOGY, AMINO ACID;

RATTUS;

EID: 70350523600     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.07.009     Document Type: Article

References (71)

1. Maher E.A., Furnari F.B., Bachoo R.M., Rowitch D.H., Louis D.N., Cavenee W.K., and DePinho R.A. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 15 11 (2001) 1311-1333
2. Ichimura K., Ohgaki H., Kleihues P., and Collins V.P. Molecular pathogenesis of astrocytic tumours. J. Neurooncol. 70 2 (2004) 137-160
3. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., Scheithauer B.W., and Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114 2 (2007) 97-109
4. Sulman E.P., Guerrero M., and Aldape K. Beyond grade: molecular pathology of malignant gliomas. Semin. Radiat. Oncol. 19 3 (2009) 142-149
5. Collins V.P. Gliomas. Cancer Surv. 32 (1998) 37-51
6. Huang T.T., Sarkaria S.M., Cloughesy T.F., and Mischel P.S. Targeted therapy for malignant glioma patients: lessons learned and the road ahead. Neurotherapeutics 6 3 (2009) 500-512
7. Sonabend A.M., Ulasov I.V., and Lesniak M.S. Gene therapy trials for the treatment of high-grade gliomas. Gene Ther. Mol. Biol. 11 (A) (2007) 79-92
8. Gill III T.J., Smith G.J., Wissler R.W., and Kunz H.W. The rat as an experimental animal. Science 245 4915 (1989) 269-276
9. Barth R.F. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J. Neurooncol. 36 1 (1998) 91-102
10. Barth R.F., and Kaur B. Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J. Neurooncol. (2009)
11. Grobben B., De Deyn P.P., and Slegers H. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res. 310 3 (2002) 257-270
12. Grasso R.J. Transient inhibition of cell proliferation in rat glioma monolayer cultures by cortisol. Cancer Res. 36 7 (PT 1) (1976) 2408-2414
13. Wolff J.E., Molenkamp G., Hotfilder M., and Laterra J. Dexamethasone inhibits glioma-induced formation of capillary like structures in vitro and angiogenesis in vivo. Klin. Padiatr. 209 4 (1997) 275-277
14. Nahaczewski A.E., Fowler S.B., and Hariharan S. Dexamethasone therapy in patients with brain tumors-a focus on tapering. J. Neurosci. Nurs. 36 6 (2004) 340-343
15. Van Roost D., Hartmann A., and Quade G. Changes of cerebral blood flow following dexamethasone treatment in brain tumour patients. A Xe/CT study. Acta Neurochir. (Wien) 143 1 (2001) 37-43 (discussion 43-34)
16. Kaup B., Schindler I., Knupfer H., Schlenzka A., Preiss R., and Knupfer M.M. Time-dependent inhibition of glioblastoma cell proliferation by dexamethasone. J. Neurooncol. 51 2 (2001) 105-110
17. Whitfield G.K., Jurutka P.W., Haussler C.A., and Haussler M.R. Steroid hormone receptors: evolution, ligands, and molecular basis of biologic function. J. Cell Biochem. Suppl. 32-33 (1999) 110-122
18. Armelin M.C., and Armelin H.A. Glucocorticoid hormone modulation of both cell surface and cytoskeleton related to growth control of rat glioma cells. J. Cell Biol. 97 2 (1983) 459-465
19. Benda P., Lightbody J., Sato G., Levine L., and Sweet W. Differentiated rat glial cell strain in tissue culture. Science 161 839 (1968) 370-371
20. Armelin M.C., Oliveira M.L., Mercado J.M., Sasahara R.M., Valentini S.R., and Carvalho L.H. Molecular genetic approach to cell proliferation control and neoplasia. Braz. J. Med. Biol. Res. 29 7 (1996) 911-919
21. Vedoy C.G., and Sogayar M.C. Isolation and characterization of genes associated with the anti-tumor activity of glucocorticoids. Brain Res. Mol. Brain Res. 106 1-2 (2002) 57-69
22. Demasi M.A., Montor W.R., Ferreira G.B., Pimenta D.C., Labriola L., and Sogayar M.C. Differential proteomic analysis of the anti-proliferative effect of glucocorticoid hormones in ST1 rat glioma cells. J. Steroid Biochem. Mol. Biol. 103 2 (2007) 137-148
23. Kim T.A., Lim J., Ota S., Raja S., Rogers R., Rivnay B., Avraham H., and Avraham S. NRP/B, a novel nuclear matrix protein, associates with p110 (RB) and is involved in neuronal differentiation. J. Cell Biol. 141 3 (1998) 553-566
24. Kim T.A., Ota S., Jiang S., Pasztor L.M., White R.A., and Avraham S. Genomic organization, chromosomal localization and regulation of expression of the neuronal nuclear matrix protein NRP/B in human brain tumors. Gene 255 1 (2000) 105-116
25. Hernandez M.C., Andres-Barquin P.J., Martinez S., Bulfone A., Rubenstein J.L., and Israel M.A. ENC-1: a novel mammalian kelch-related gene specifically expressed in the nervous system encodes an actin-binding protein. J. Neurosci. 17 9 (1997) 3038-3051
26. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., and Vogelstein B. A model for p53-induced apoptosis. Nature 389 6648 (1997) 300-305
27. Berezney R., and Coffey D.S. Identification of a nuclear protein matrix. Biochem. Biophys. Res. Commun. 60 4 (1974) 1410-1417
28. Stein G.S., Stein J.L., Lian J.B., Van Wijnen A.J., Montecino M., Javed A., Zaidi S.K., Young D., Choi J.Y., and Pockwinse S. Nuclear microenvironments: an architectural platform for the convergence and integration of transcriptional regulatory signals. Eur. J. Histochem. 48 1 (2004) 65-76
29. Nickerson J. Experimental observations of a nuclear matrix. J. Cell Sci. 114 Pt 3 (2001) 463-474
30. Tsutsui K.M., Sano K., and Tsutsui K. Dynamic view of the nuclear matrix. Acta Med. Okayama 59 4 (2005) 113-120
31. Davie J.R., Samuel S., Spencer V., Bajno L., Sun J., Chen H.Y., and Holth L.T. Nuclear matrix: application to diagnosis of cancer and role in transcription and modulation of chromatin structure. Gene Ther. Mol. Biol. 1 (1998) 509-528
32. Zink D., Fischer A.H., and Nickerson J.A. Nuclear structure in cancer cells. Nat. Rev. Cancer 4 9 (2004) 677-687
33. Loidl P., and Eberharter A. Nuclear matrix and the cell cycle. Int. Rev. Cytol. 162B (1995) 377-403
34. Zhao L., Gregoire F., and Sul H.S. Transient induction of ENC-1, a Kelch-related actin-binding protein, is required for adipocyte differentiation. J. Biol. Chem. 275 22 (2000) 16845-16850
35. Albagli O., Dhordain P., Deweindt C., Lecocq G., and Leprince D. The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins. Cell Growth Differ. 6 9 (1995) 1193-1198
36. Kim T.A., Jiang S., Seng S., Cha K., Avraham H.K., and Avraham S. The BTB domain of the nuclear matrix protein NRP/B is required for neurite outgrowth. J. Cell Sci. 118 Pt 23 (2005) 5537-5548
37. Varkey J.P., Muhlrad P.J., Minniti A.N., Do B., and Ward S. The Caenorhabditis elegans spe-26 gene is necessary to form spermatids and encodes a protein similar to the actin-associated proteins kelch and scruin. Genes Dev. 9 9 (1995) 1074-1086
38. Liang X.Q., Avraham H.K., Jiang S., and Avraham S. Genetic alterations of the NRP/B gene are associated with human brain tumors. Oncogene 23 35 (2004) 5890-5900
39. Seng S., Avraham H.K., Jiang S., Yang S., Sekine M., Kimelman N., Li H., and Avraham S. The nuclear matrix protein, NRP/B, enhances Nrf2-mediated oxidative stress responses in breast cancer cells. Cancer Res. 67 18 (2007) 8596-8604
40. Wang X.J., and Zhang D.D. Ectodermal-neural cortex 1 down-regulates Nrf2 at the translational level. PLoS One 4 5 (2009) e5492
41. Kim S.G., Jang S.J., Soh J., Lee K., Park J.K., Chang W.K., Park E.W., and Chun S.Y. Expression of ectodermal neural cortex 1 and its association with actin during the ovulatory process in the rat. Endocrinology (2009)
42. Seng S., Avraham H.K., Birrane G., Jiang S., Li H., Katz G., Bass C.E., Zagozdzon R., and Avraham S. NRP/B mutations impair Nrf2-dependent NQO1 induction in human primary brain tumors. Oncogene 28 3 (2009) 378-389
43. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., and Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25 17 (1997) 3389-3402
44. Kent W.J. BLAT-the BLAST-like alignment tool. Genome Res. 12 4 (2002) 656-664
45. Chenna R., Sugawara H., Koike T., Lopez R., Gibson T.J., Higgins D.G., and Thompson J.D. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 31 13 (2003) 3497-3500
46. Armelin M.C., Stocco R.C., and Armelin H.A. Control of rat C6 glioma cell proliferation: uncoupling of the inhibitory effects of hydrocortisone hormone in suspension and monolayer cultures. J. Cell Biol. 97 2 (1983) 455-458
47. Chirgwin J.M., Przybyla A.E., MacDonald R.J., and Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18 24 (1979) 5294-5299
48. Ewing B., and Green P. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res. 8 3 (1998) 186-194
49. Ewing B., Hillier L., Wendl M.C., and Green P. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res. 8 3 (1998) 175-185
50. Gordon D., Abajian C., and Green P. Consed: a graphical tool for sequence finishing. Genome Res. 8 3 (1998) 195-202
51. Schmittgen T.D. Real-time Quantitative PCR Methods (San Diego, CA) vol. 25 (4) (2001) pp. 383-385
52. Jin N., Chen W., Blazar B.R., Ramakrishnan S., and Vallera D.A. Gene therapy of murine solid tumors with T cells transduced with a retroviral vascular endothelial growth factor-immunotoxin target gene. Hum. Gene Ther. 13 4 (2002) 497-508
53. Pengue G., Calabro V., Bartoli P.C., Pagliuca A., and Lania L. Repression of transcriptional activity at a distance by the evolutionarily conserved KRAB domain present in a subfamily of zinc finger proteins. Nucleic Acids Res. 22 15 (1994) 2908-2914
54. Zollman S., Godt D., Prive G.G., Couderc J.L., and Laski F.A. The BTB domain, found primarily in zinc finger proteins, defines an evolutionarily conserved family that includes several developmentally regulated genes in Drosophila. Proc. Natl. Acad. Sci. U.S.A. 91 22 (1994) 10717-10721
55. Collins T., Stone J.R., and Williams A.J. All in the family: the BTB/POZ, KRAB, and SCAN domains. Mol. Cell Biol. 21 11 (2001) 3609-3615
56. Adams J., Kelso R., and Cooley L. The kelch repeat superfamily of proteins: propellers of cell function. Trends Cell Biol. 10 1 (2000) 17-24
57. Stogios P.J., and Prive G.G. The BACK domain in BTB-kelch proteins. Trends Biochem. Sci. 29 12 (2004) 634-637
58. Hernandez M.C., Andres-Barquin P.J., Holt I., and Israel M.A. Cloning of human ENC-1 and evaluation of its expression and regulation in nervous system tumors. Exp. Cell Res. 242 2 (1998) 470-477
59. Crossin K.L., Tai M.H., Krushel L.A., Mauro V.P., and Edelman G.M. Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation. Proc. Natl. Acad. Sci. U.S.A. 94 6 (1997) 2687-2692
60. Piette C., Munaut C., Foidart J.M., and Deprez M. Treating gliomas with glucocorticoids: from bedside to bench. Acta Neuropathol. 112 6 (2006) 651-664
61. Almeida O.F., Conde G.L., Crochemore C., Demeneix B.A., Fischer D., Hassan A.H., Meyer M., Holsboer F., and Michaelidis T.M. Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J. 14 5 (2000) 779-790
62. Meredith Jr. J.E., Fazeli B., and Schwartz M.A. The extracellular matrix as a cell survival factor. Mol. Biol. Cell 4 9 (1993) 953-961
63. Stupack D.G., Puente X.S., Boutsaboualoy S., Storgard C.M., and Cheresh D.A. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol. 155 3 (2001) 459-470
64. Cifone M.A. In vitro growth characteristics associated with benign and metastatic variants of tumor cells. Cancer Metastasis Rev. 1 4 (1982) 335-347
65. Freedman V.H., and Shin S.I. Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3 4 (1974) 355-359
66. Macpherson I., and Montagnier L. Agar suspension culture for the selective assay of cells transformed by Polyoma virus. Virology 23 (1964) 291-294
67. Assoian R.K. Anchorage-dependent cell cycle progression. J. Cell Biol. 136 1 (1997) 1-4
68. Bohmer R.M., Scharf E., and Assoian R.K. Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1. Mol. Biol. Cell 7 1 (1996) 101-111
69. Louis D.N. Molecular pathology of malignant gliomas. Annu. Rev. Pathol. 1 (2006) 97-117
70. Louis D.N., and Gusella J.F. A tiger behind many doors: multiple genetic pathways to malignant glioma. Trends Genet. 11 10 (1995) 412-415
71. Alonso M.M., Alemany R., Fueyo J., and Gomez-Manzano C. E2F1 in gliomas: a paradigm of oncogene addiction. Cancer Lett. 263 2 (2008) 157-163